ArticleTherapeutic advances in infectious disease
Risk factors for multiple skin abscesses among community-recruited people who inject drugs in Los Angeles, CA, and Denver, CO: a cross-sectional study.
Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Introduction: Skin abscesses are one of the most common infections among people who inject drugs (PWID). Objective: To examine factors associated with the frequency of abscesses in the previous 3 months among PWID. Design: We conducted a cross-sectional analysis of baseline data from a prospective longitudinal cohort of PWID. Methods: Between April 2021 and November 2022, PWID were recruited from community settings in Los Angeles, CA, and Denver, CO. Participants completed an interview covering sociodemographic, drug use, and related risk behaviors. Participants were asked if they had abscesses in the last 3 months. Those reporting " Results: Among participants ( Conclusion: Our findings underscore a multi-level approach to reducing abscesses in this population. Increased education around safe injection practices, institutional interventions-that is, addressing healthcare stigmatization and expanding clinical harm reduction-as well as structural interventions (safe supply, overdose prevention programs, housing) should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.